Progress on pharmacogenetic study in psychiatry and future prospects of order-made drug therapy for mental disorders
Shimoda, K.
Seishin Shinkeigaku Zasshi 111(12): 1546-1551
2009
ISSN/ISBN: 0033-2658 PMID: 20344870 Document Number: 634450
Document emailed within 1 workday
Related Documents
Yamashita, I. 2004: The past and future of psychiatry and mental treatment in Japan from the standpoint of clinical psychiatry Seishin Shinkeigaku Zasshi 106(9): 1130-1134Ueshima, K. 1993: Recent progress on drug therapy of mental diseases Seishin Shinkeigaku Zasshi 95(9): 671-681
Pöldinger, W. 1975: Future prospects in psychiatry Schweizer Archiv für Neurologie Neurochirurgie und Psychiatrie 117(1): 75-84
Kagomoto, T. 2009: Present status and future prospects of pediatric and adolescent psychiatry Seishin Shinkeigaku Zasshi 111(11): 1370-1372
Zheng, Y. 2020: Child psychiatry in China: Present situation and future prospects Pediatric Investigation 4(2): 79-83
Jha, P. 2002: Avoidable mortality in India: past progress and future prospects National Medical Journal of India 15(Suppl): 32-36
Švab, V. 2018: Stigma in mental disorders: what is psychiatry able to do? Psychiatria Danubina 30(Suppl 4): 172-174
Fukuda, Y. 2015: Evidence-based Prospects for the Future of Mental Health Policies in Japan Seishin Shinkeigaku Zasshi 117(7): 519-524
Regier, D.A.; Farmer, M.E.; Rae, D.S.; Locke, B.Z.; Keith, S.J.; Judd, L.L.; Goodwin, F.K. 1990: Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study JAMA 264(19): 2511-2518
Vas, A.; Gachályi, B.; Káldor, A. 1987: Simultaneous microsomal monooxygenase enzyme system induction and inhibition, and the influence of the pharmacogenetic background: potential hazards in multi-drug therapy? International Journal of Clinical Pharmacology Therapy and Toxicology 25(7): 410
McKinnon, J.E.; Mellors, J.W.; Swindells, S. 2009: Simplification strategies to reduce antiretroviral drug exposure: progress and prospects Antiviral Therapy 14(1): 1-12
Eyckmans, L. 1990: Drug resistance of Plasmodium falciparum. Consequences and future prospects Presse Medicale 19(1): 9-10
Kiso, M.; Kawaoka, Y. 2012: Anti-influenza drug--current status and future prospects Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 8): 574-578
Sawa, A. 2007: Reevaluation of electroconvulsive therapy in the progress of psychiatry and patient rehabilitation Seishin Shinkeigaku Zasshi 109(4): 365-372
Gurski, K.J.; Steller, M.A. 1997: Progress and prospects in vaccine therapy for gynecologic cancers Oncology 11(11): 1727-1734; 1739-1740; Discussion 1740
Alhenc-Gelas, Fçois.; Parmentier, L.; Bisagni, A. 2003: Pharmacogenetic and pharmacogenomic studies. Impact on drug discovery and drug development Therapie 58(3): 275-282
Sukhanov, V.A.; Piruzian, L.A. 2004: Pharmacogenetic challenges in the treatment of mental diseases Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 104(8): 83-86
Byrnes, A.P. 2005: Challenges and future prospects in gene therapy Idrugs: the Investigational Drugs Journal 8(12): 993-996
Krivoy, N.; Zuckerman, T.; Elkin, H.; Froymovich, L.; Rowe, J.M.; Efrati, E. 2012: Pharmacokinetic and pharmacogenetic analysis of oral busulfan in stem cell transplantation: prediction of poor drug metabolism to prevent drug toxicity Current Drug Safety 7(3): 211-217
Thomas, K.L.H.; Ellingrod, V.L.; Bishop, J.R.; Keiser, M.J. 2010: A pilot study of the pharmacodynamic impact of SSRI drug selection and beta-1 receptor genotype (ADRB1) on cardiac vital signs in depressed patients: a novel pharmacogenetic approach Psychopharmacology Bulletin 43(1): 11-22